# OnCo record hypericin-sgx301 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/hypericin-sgx301/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "hypericin-sgx301" ;
  schema:name "Synthetic hypericin"@en ;
  schema:alternateName "Hypericin"@en, "SGX301"@en, "Hypericin ointment"@en, "HyBryte" ;
  schema:description "HyBryte is an ointment containing synthetic hypericin, the active pigment of St John's wort. Rubbed on patches of cutaneous T-cell lymphoma and switched on with ordinary visible light, it kills the lymphoma cells in the skin without ultraviolet light."@en ;
  schema:url <https://onco.cc/drugs/hypericin-sgx301/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Hypericin> ;
  schema:citation <https://en.wikipedia.org/wiki/Hypericin> ;
  onco:status "phase-3" ;
  onco:tag "subtype-drugs-wave" ;
  onco:modality "Topical photosensitiser activated by visible light" ;
  onco:cancers <https://onco.cc/cancers/cutaneous-t-cell-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/photodynamic-therapy-lasers/> ;
  onco:companies <https://onco.cc/companies/soligenix/> .